Gilead Sciences GILD Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $8.51B+1,673% | $480M-91.4% | $5.61B+22.9% | $4.57B-26.4% | ||
| $894M+7.1% | $835M+9.0% | $766M+20.3% | $637M+0.3% | ||
| $10.02B-7.5% | $10.83B+35.2% | $8.01B-11.8% | $9.07B-20.3% | ||
| $563M+7.6% | $523M-10.6% | $585M-19.6% | $728M+25.7% | ||
| $1.07B-77.9% | $4.84B+320% | $1.15B-35.9% | $1.8B+13.4% | ||
| -$4.79B-39.0% | -$3.45B-52.3% | -$2.27B+8.2% | -$2.47B+21.2% | ||
| $4B+2.2% | $3.92B+2.9% | $3.81B+2.7% | $3.71B+2.9% | ||
| $1.92B+67.1% | $1.15B+15.0% | $1B-28.4% | $1.4B+156% | ||
| -$7.75B— | —— | -$5.13B+20.8% | -$6.47B+27.1% | ||
| —— | $3.91B+480% | $673M+809% | $74M— | ||
| $9.46B-8.2% | $10.31B+38.9% | $7.42B-11.1% | $8.34B-22.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gilead Sciences generate?
- Gilead Sciences (GILD) generated $10.8B in operating cash flow over the trailing twelve months.
- What is Gilead Sciences's free cash flow?
- After $576.0M of capital expenditures, Gilead Sciences's free cash flow was $10.2B over the trailing twelve months, up 3.9% year over year.
- Where does Gilead Sciences's cash flow data come from?
- Every line is extracted from Gilead Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
